News Clip2:36
Bloomberg

Coronavirus Is Not Too Complicated, Says Moderna CEO

Higher Ed
Jun.15 -- Stephane Bancel, chief executive officer of Moderna, Inc., talks about the chances of getting a vaccine for coronavirus made. He appears on "Leadership Live With David Rubenstein."
News Clip10:15
Bloomberg

Moderna Starts Phase Three Trial, U.S. Funding Nears $1 Billion

Higher Ed
Jul.27 -- Moderna Chief Executive Officer Stephane Bancel discusses the company beginning a late-stage trial on its experimental vaccine for Covid-19. He speaks on "Bloomberg Markets: European Close."
News Clip0:51
Bloomberg

Trump Criticizes Governors for Re-Opening Too Slowly

Higher Ed
Jul.27 -- President Donald Trump says economic recovery has been "very strong" while adding that a number of governors are moving too slowly to open their states’ economies amid the coronavirus pandemic. He speaks at an event in North...
News Clip5:02
Bloomberg

Covid-19 Plasma Treatment Improves Mortality: Johns Hopkins

Higher Ed
Aug.06 -- Johns Hopkins University Professor of Nursing Jason Farley discusses plasma treatments for covid-19, the vaccine pipeline, and concerns about youth exposure to the coronavirus. He speaks with Bloomberg’s Francine Lacqua on...
News Clip1:14
Bloomberg

Trump: Three Vaccine Candidates Looking 'Really Good'

Higher Ed
Jul.02 -- President Donald Trump says three vaccine candidates for Covid-19 are "looking really, really good" in trials. He also says the military is standing by, ready to distribute the vaccines. He speaks at a White House event. (Excerpt)
News Clip6:48
Bloomberg

J&J Vaccine Helps, But Is Not a Game Changer: Johns Hopkins

Higher Ed
Mar.01 -- Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses the vaccination race against virus variants, approval of the Johnson & Johnson vaccine, and falling hospitalization rates following the...
News Clip5:33
Bloomberg

Global Covid Hot Spots to Extend Into 2022: Johns Hopkins

Higher Ed
Apr.06 -- Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses the spread of Covid-19 from pandemic hot spots, achieving herd immunity via vaccinations, and concerns about mass gatherings in the U.S. He...
News Clip5:30
Bloomberg

FAANG Stocks Are Overvalued, the Lerner Group Says

Higher Ed
Dec.27 -- Vanessa Martinez, managing director and partner of the Lerner Group, discusses the outlook for technology and e-commerce stocks, and looks at what the Covid-19 vaccinations and President Donald Trump's signing of a bill...
News Clip10:10
Bloomberg

$2,000 Stimulus Checks Would be a Mistake: Summers

Higher Ed
Dec.25 -- Former U.S. Treasury Secretary Lawrence H. Summers, a Wall Street Week contributor and adviser to Pres.-elect Biden's campaign, says that increasing direct stimulus payments to $2,000 would risk temporarily overheating the...
News Clip5:35
Bloomberg

Astra-Oxford Covid-19 Vaccine Gets U.K. Clearance

Higher Ed
Dec.30 -- AstraZeneca Plc and the University of Oxford’s coronavirus vaccine won U.K. clearance, marking the first approval worldwide for a shot that’s faced questions but will be key to mass immunizations. Deenan Pillay, virologist at...
News Clip2:48
Sky News

FRANCE: President Macron has announced a new nationwide lockdown

Higher Ed
VOICED: President Macron has announced a new - nationwide - lockdown in France. The strict restrictions - already in place in several regions - aim to combat a third wave of COVID-19 that is affecting Europe. The President made the...
News Clip1:42
Bloomberg

J&J Vaccine Manufacturing Error Affects 15 Million Doses

Higher Ed
Apr.01 -- A manufacturing error at a plant involved in Covid-19 vaccine production affected 15 million doses worth of an ingredient for Johnson & Johnson’s vaccine, according to two sources familiar with the matter. Rachel Chang reports...
News Clip17:13
Bloomberg

Serum Institute CEO Poonawalla on Vaccine Diplomacy

Higher Ed
Mar.17 -- Adar Poonawalla, CEO, Serum Institute of India, talks with Bloomberg’s Haslinda Amin at the Bloomberg Equality Summit about running the world’s largest vaccine manufacturer amid a global pandemic.
News Clip1:20
Bloomberg

Singapore Moves Back Towards Covid Lockdown on Rising Cases

Higher Ed
May.14 -- Singapore is returning to lockdown-like conditions after seeing a rising number of untraceable virus infections. Bloomberg’s Derek Wallbank reports.
News Clip1:59
Bloomberg

Biden Pledges to Send Millions of FDA-Authorized Vaccines Abroad

Higher Ed
May.17 -- President Joe Biden says he’ll release 20 million doses of vaccines from Pfizer Inc., Moderna Inc. or Johnson & Johnson to foreign nations by June. He spoke at the White House on Monday.
News Clip1:41
Curated Video

Newsy’s Latest Headlines

Higher Ed
President Biden says the U.S. is still on track to meet his vaccination goals despite distribution delays. Plus, other top headlines of the day.
News Clip4:21
Bloomberg

Moderna Covid Booster Shots Prove Effective Against Variants

Higher Ed
May.05 -- Moderna's mid-stage trials show its booster vaccine shots were effective against strains of the coronavirus that emerged from Brazil and South Africa. Moderna co-founder Noubar Afeyan speaks exclusively with Bloomberg...
News Clip5:44
Bloomberg

'Overshoot' To Government Bond Yields, LGT Bank Asia's Hofer Says

Higher Ed
Mar.04 -- LGT Bank Asia Chief Investment Strategist Stefan Hofer think there is currently an “overshoot” to government bond yields. He was speaking with Haslinda Amin and Rishaad Salamat on "Bloomberg Markets: Asia."
News Clip0:55
Curated Video

France Reports First Case Of More Contagious COVID-19 Variant

Higher Ed
A man who returned to France from London on December 19th tested positive for the new COVID-19 variant.
News Clip4:20
Bloomberg

Vaccinated Show Decrease in Covid Spread, Death: Johns Hopkins

Higher Ed
Apr.20 -- Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses vaccination of younger adults and Covid-19 transmission after vaccination. The Johns Hopkins Bloomberg School of Public Health is supported by...
News Clip2:43
Bloomberg

EU Says J&J Vaccine Benefits Outweigh Risks Despite Clots

Higher Ed
Apr.20 -- The European Union’s drug regulator said the benefits of Johnson & Johnson’s Covid-19 vaccine outweighs the risks as it warned of a possible link to cases of rare blood clots. Bloomberg’s Tim Loh reports.
News Clip3:04
Curated Video

Some Colleges Will Require Students To Be Vaccinated

Higher Ed
California's two public university systems top list of colleges imposing mandate.
News Clip6:51
Bloomberg

Booking CEO Says Travelers Need to Show They Are Safe to Fly

Higher Ed
Apr.08 -- Booking Holdings Inc. Chief Executive Officer Glenn Fogel says demand for travel is picking up, but it's not near 2019 levels. He says we need a way to show that people are safe to travel. He speaks on "Bloomberg Markets."
News Clip6:13
Bloomberg

Inflation in Short-Term Will Have Very Scary Numbers: Citigroup

Higher Ed
May.09 -- Mo Apabhai, head of Asia trading strategy at Citigroup Global Markets, discusses inflation and his asset allocation. He speaks on “Bloomberg Daybreak: Asia.”